These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3892319)

  • 41. Effects of ranitidine treatment on patients with asthma and a history of gastro-oesophageal reflux: a double blind crossover study.
    Ekström T; Lindgren BR; Tibbling L
    Thorax; 1989 Jan; 44(1):19-23. PubMed ID: 2648642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Daytime reduction of gastro-oesophageal reflux after healing of oesophagitis and its value as an indicator of favourable response to maintenance treatment.
    Pace F; Sangaletti O; Bianchi Porro G
    Gut; 1990 Sep; 31(9):1025-9. PubMed ID: 2210448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of reflux oesophagitis with ranitidine.
    Wesdorp IC; Dekker W; Klinkenberg-Knol EC
    Gut; 1983 Oct; 24(10):921-4. PubMed ID: 6311693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Famotidine in the management of gastro-oesophageal reflux.
    Okoth FA; Lule GN; Ogutu EO; Pilczer S; Dubois C
    East Afr Med J; 1994 Jan; 71(1):44-8. PubMed ID: 8055765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of ranitidine on symptom relief and quality of life of patients with gastro-oesophageal reflux disease.
    Chal KL; Stacey JH; Sacks GE
    Br J Clin Pract; 1995; 49(2):73-7. PubMed ID: 7779648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unusual presentation of mucosal hypersensitivity secondary to gastroesophageal reflux disease.
    Baron TH; Richter JE; Singh S; Tennyson GS; Andres JM
    Am J Gastroenterol; 1993 Feb; 88(2):289-92. PubMed ID: 8424436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Therapy of esophageal reflux disease].
    Rösch W
    Dtsch Med Wochenschr; 1982 Mar; 107(10):389-91. PubMed ID: 6277588
    [No Abstract]   [Full Text] [Related]  

  • 50. Double-blind crossover study of ranitidine and ebrotidine in gastro-esophageal reflux disease.
    Sito E; Thor PJ; M[aczka M; Lorens K; Konturek SJ; Maj A
    J Physiol Pharmacol; 1993 Sep; 44(3):259-72. PubMed ID: 8241527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
    Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nizatidine versus placebo in gastro-oesophageal reflux disease: a 6-week, multicentre, randomised, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group.
    Cloud ML; Offen WW
    Br J Clin Pract Suppl; 1994 Nov; 76():11-9. PubMed ID: 7794700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral ranitidine and duration of gastric pH >4.0 in infants with persisting reflux symptoms.
    Salvatore S; Hauser B; Salvatoni A; Vandenplas Y
    Acta Paediatr; 2006 Feb; 95(2):176-81. PubMed ID: 16449023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Therapeutic strategies in non-erosive gastro-oesophageal reflux disease].
    Domínguez Antonaya M; Moreno Sánchez D; González Alonso R
    Med Clin (Barc); 2004 Sep; 123(9):352-6. PubMed ID: 15388040
    [No Abstract]   [Full Text] [Related]  

  • 55. Gastric secretion and reflux pattern in reflux oesophagitis before and during ranitidine treatment.
    Johansson KE; Tibbling L
    Scand J Gastroenterol; 1986 May; 21(4):487-92. PubMed ID: 3523741
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cimetidine 2 X 400 mg in the treatment of reflux esophagitis?].
    Koelz HR
    Z Gastroenterol; 1984 Aug; 22(8):379-81. PubMed ID: 6091354
    [No Abstract]   [Full Text] [Related]  

  • 57. Omeprazole versus ranitidine in erosive oesophagitis.
    Zeitoun P; Desjars De Keranroué N; Isal JP
    Lancet; 1987 Sep; 2(8559):621-2. PubMed ID: 2887900
    [No Abstract]   [Full Text] [Related]  

  • 58. [Gastroesophageal reflux disease and reflux esophagitis. Therapeutic modifiability by bethanechol chloride].
    Hunold W
    ZFA (Stuttgart); 1982 Oct; 58(29):1623-8. PubMed ID: 6129755
    [No Abstract]   [Full Text] [Related]  

  • 59. Ambulatory pH monitoring of gastro-oesophageal reflux in "morning dipper" asthmatics.
    Nagel RA; Brown P; Perks WH; Wilson RS; Kerr GD
    BMJ; 1988 Nov; 297(6660):1371-3. PubMed ID: 3146369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of smoking in a controlled study of ranitidine treatment in gastroesophageal reflux disease.
    Berenson MM; Sontag S; Robinson MG; McCallum RM
    J Clin Gastroenterol; 1987 Oct; 9(5):499-503. PubMed ID: 3316371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.